IMVT Latest Press Releases

-- May 20, 2026 --

Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 Globe Newswire 7:00 AM

-- May 11, 2026 --

Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026 Globe Newswire 4:05 PM

-- April 2, 2026 --

Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED) Globe Newswire 5:00 AM

-- February 17, 2026 --

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Immunovant, Inc. (NASDAQ: IMVT) PRNewswire 10:48 AM

-- February 6, 2026 --

Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025 Globe Newswire 7:00 AM

-- January 23, 2026 --

Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026 Globe Newswire 5:25 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software